The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (17 analysts) rates it hold, with a mean price target of $16.
Conagra Brands
CAG · a US exchange · USD · Market cap $7.0B · 18,300 employees
Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company primarily in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 23:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 14.70 against the desk's fair-value range, base estimate 15.16, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Conagra Brands holds its Distribution at $14.70. Consolidating, no directional conviction, held for 4 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 4 days |
| Price at the screen | $14.70 |
| Valuation | N/A trailing · 9.47 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | -0.03 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 38.54% | Below 33% | Interest-bearing debt is 38.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 4.00% | Below 49% | Money owed to the company is 4.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.02% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 3% discount to our $15.16 fair value, weak competitive moat, 3.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 3.1% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Hold. The average target sits −5% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsPackaged food shelves hide weak returns and debt
Walk down any supermarket aisle and the familiar brands sit on every shelf. Yet Conagra carries a debt load that trips the ethical screen while posting a negative 17% profit margin and negative 25% return on equity. Revenue edges up just 4% and the moat looks weak, so the business earns an AVOID rating despite a modest 7% gap to fair value.
The forward multiple of 9.1 times offers little comfort once peak earnings risk and thin growth enter the frame. Sixteen analysts sit on hold with a median target matching the current price, confirming the market sees no obvious catalyst. Currency moves or input costs could quickly widen the gap between reported numbers and cash reality.
High leverage remains the core ethical failure here, and cyclical packaged-food margins have a habit of disappointing when volumes soften. Analysis, not advice.
| Forward P/E | 9.5xexpensive even after accounting for its growth |
| EPS, trailing | -4.00 |
| EPS, forward | 1.55 |
| Revenue growth | +3.6%slow but positive growth |
| Profit margin | -17.0%currently unprofitable |
| Return on equity | -25.1%not currently earning a positive return on equity |
| FCF yield | 12.21% |
| Dividend yield | 991.00% |
| Debt to equity | 1.18a meaningful debt load worth watching |
| Current ratio | 0.90below 1: short-term bills exceed liquid assets |
| Beta | -0.03barely tracks the market's swings |
| Short interest, float | 0.11% |
| 52-week range | 12.53 - 20.32 |
| Moat | WEAK |
| Market cap | $7.0B |
| Employees | 18,300 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCAG trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (17 analysts) rates it hold, with a mean price target of $16.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 6%. The street (17 analysts) rates it hold, with a mean price target of $16.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-14 | MULLIGAN JOHN J | Director | 17,500 | $250,402 | |
| 2026-03-02 | MULLIGAN JOHN J | Director | 3,228 | · | |
| 2026-03-02 | SATRIANO PIETRO | Director | 3,228 | · | |
| 2026-03-02 | MARSHALL RUTH ANN | Director | 1,629 | $31,250 | |
| 2025-12-01 | MARSHALL RUTH ANN | Director | 1,768 | $31,250 | |
| 2025-11-04 | NAPIER MELISSA C | Officer | 13,011 | $223,659 | |
| 2025-10-07 | BROWN THOMAS K | Director | 10,000 | $187,200 | |
| 2025-09-02 | MARSHALL RUTH ANN | Director | 1,664 | $31,250 | |
| 2025-07-24 | MARBERGER DAVID S | Chief Financial Officer | 11,419 | $220,387 | |
| 2025-07-24 | CONNOLLY SEAN | Chief Executive Officer | 42,935 | $828,646 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-07-13 | Rick Scott | Republican | sell | 100K–250K |
| 2026-06-30 | Gil Cisneros | Democrat | buy | 15K–50K |
| 2026-06-16 | Gil Cisneros | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $13.93 | -4.5% | · | $955 | -4.5% |
| 2 months | $14.81 | -10.1% | $0.35 | $922 | -7.8% |
| 3 months | $15.77 | -15.6% | $0.35 | $866 | -13.4% |
| 6 months | $16.83 | -21.0% | $0.70 | $832 | -16.8% |
| 1 year | $20.65 | -35.6% | $1.40 | $712 | -28.8% |
| 2 years | $25.60 | -48.0% | $2.80 | $629 | -37.1% |
| 3 years | $28.68 | -53.6% | $4.20 | $610 | -39.0% |
| 5 years | $28.94 | -54.0% | $6.77 | $694 | -30.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CAG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.